Get the Stockscreener App
1.17
0.85%
-0.01
After Hours:
1.15
-0.02
-1.71%
Polyrizon Ltd stock is traded at $1.17, with a volume of 288.99K.
It is down -0.85% in the last 24 hours and down -2.50% over the past month.
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.
See More
Previous Close:
$1.18
Open:
$1.15
24h Volume:
288.99K
Relative Volume:
0.06
Market Cap:
$7.01M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+6.36%
1M Performance:
-2.50%
6M Performance:
-98.83%
1Y Performance:
+0.00%
1-Day Range:
$1.1101
$1.19
1-Week Range:
$1.11
$1.28
52-Week Range:
$0.55
$1,200.00
Polyrizon Ltd Stock (PLRZ) Company Profile
Compare PLRZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLRZ
Polyrizon Ltd
|
1.17 | 7.07M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Polyrizon Ltd Stock (PLRZ) Latest News
Can Polyrizon Ltd. stock beat market expectations this quarterWeekly Volume Report & Fast Gain Swing Alerts - newser.com
How Polyrizon Ltd. stock compares to growth peersJuly 2025 News Drivers & Smart Money Movement Alerts - newser.com
Is Polyrizon Ltd. stock reversal real or fakeTrade Entry Summary & Breakout Confirmation Trade Signals - newser.com
Can Polyrizon Ltd. rally from current levelsJuly 2025 Update & High Accuracy Swing Entry Alerts - newser.com
Will Polyrizon Ltd. stock keep outperforming rivals2025 Sector Review & Fast Exit/Entry Strategy Plans - newser.com
How to integrate Polyrizon Ltd. into portfolio analysis toolsQuarterly Trade Summary & Fast Moving Stock Watchlists - newser.com
Is Polyrizon Ltd. stock affected by interest rate hikesDip Buying & Verified Momentum Stock Watchlist - newser.com
Visualizing Polyrizon Ltd. stock with heatmaps2025 Price Action Summary & Safe Entry Zone Tips - newser.com
What data driven models say about Polyrizon Ltd.’s futureStock Surge & Real-Time Market Sentiment Alerts - newser.com
Applying chart zones and confluence areas to Polyrizon Ltd.2025 Growth vs Value & Free Risk Controlled Daily Trade Plans - newser.com
Analyzing Polyrizon Ltd. with multi timeframe chartsBull Run & Weekly High Potential Stock Alerts - newser.com
Applying big data sentiment scoring on Polyrizon Ltd.2025 Retail Activity & Free Real-Time Market Sentiment Alerts - newser.com
Polyrizon Reports Positive Pre-Clinical Results for PL-14 Allergy Blocker - TipRanks
Published on: 2025-10-06 07:52:02 - newser.com
Polyrizon shares preclinical results for nasal allergy blocker - Investing.com
Polyrizon Announces Positive Pre-Clinical Results: PL-14 Demonstrates Encouraging Allergen-Blocking Efficacy - The Manila Times
Polyrizon shares preclinical results for nasal allergy blocker By Investing.com - Investing.com Australia
Leading vs lagging indicators on Polyrizon Ltd. performanceJuly 2025 PostEarnings & Short-Term Swing Trade Alerts - newser.com
1.07% allergen penetration at 1hr — Polyrizon PL-14 forms effective nasal barrier in preclinical study - Stock Titan
Is Polyrizon Ltd. building a consolidation baseQuarterly Profit Review & Fast Exit and Entry Strategy Plans - newser.com
Applying sector rotation models to Polyrizon Ltd.Insider Buying & Comprehensive Market Scan Insights - newser.com
Can technical indicators confirm Polyrizon Ltd.’s reversalPortfolio Performance Summary & Fast Entry High Yield Tips - newser.com
Smart tools for monitoring Polyrizon Ltd.’s price actionMarket Sentiment Report & Growth Focused Stock Reports - newser.com
How strong is Polyrizon Ltd. stock balance sheetPortfolio Update Summary & Weekly High Return Stock Opportunities - newser.com
How moving averages guide Polyrizon Ltd. tradingShare Buyback & Growth Focused Stock Reports - newser.com
What machine learning models say about Polyrizon Ltd.July 2025 EndofMonth & Safe Entry Trade Reports - newser.com
Published on: 2025-10-03 03:17:45 - newser.com
Polyrizon Ltd Stock (PLRZ) Financials Data
There is no financial data for Polyrizon Ltd (PLRZ). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
5.15%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):